Your Cart is Empty

  • Add description, images, menus and links to your mega menu

  • A column with no settings can be used as a spacer

  • Link to your collections, sales and even external links

  • Add up to five columns

  • December 08, 2023 2 min read



    Chaga, a fungus renowned for its potential health benefits, prompts questions about its impact on anxiety levels. This article thoroughly examines the available evidence, referencing insights from UK government agencies, the NHS, and distinguished academic works from renowned UK universities and medical professionals.

    Understanding Chaga's Composition

    Before exploring its potential effects on anxiety, it is imperative to grasp the composition of Chaga (Inonotus obliquus). Rich in bioactive compounds like polysaccharides and polyphenols, Chaga's complex composition raises inquiries into how it may influence mental well-being.

    Anxiety and Adaptogenic Properties

    Adaptogens and Stress Response

    Chaga is often classified as an adaptogen, suggesting its potential to modulate the body's stress response. While this adaptogenic nature may contribute to stress reduction, its impact on anxiety requires closer examination.

    Individual Responses

    The subjective nature of anxiety responses prompts consideration of individual variability. Some anecdotal reports suggest that Chaga induces a sense of calmness, while others may not experience noticeable effects.

    Expert Opinions and Academic Research

    Limited Direct Studies

    A review of academic works from esteemed UK universities reveals a scarcity of direct studies specifically addressing Chaga's impact on anxiety. Experts stress the need for more focused research to substantiate or refute claims.

    Potential Serotonin Influence

    Some discussions within academic circles propose that Chaga may influence serotonin levels, a neurotransmitter linked to mood regulation. However, the mechanisms and extent of this influence require further exploration.

    NHS Perspective

    While acknowledging Chaga's traditional use and generally safe profile, the NHS remains cautious in endorsing specific claims related to anxiety. Individuals experiencing anxiety are advised to consult healthcare professionals for evidence-based interventions.

    Regulatory Oversight

    The Medicines and Healthcare products Regulatory Agency (MHRA), the UK government agency overseeing medicines and healthcare products, does not currently regulate Chaga for anxiety-related claims. This highlights the need for ongoing research to inform evidence-based practices.


    while Chaga's adaptogenic properties suggest potential for stress reduction, the scientific evidence supporting its impact on anxiety is currently limited. The cautious stance of UK health authorities and the NHS underscores the need for more comprehensive studies to draw definitive conclusions about Chaga's influence on anxiety levels. Individuals considering Chaga for anxiety management should approach it with prudence, recognizing the current gaps in scientific understanding and consulting healthcare professionals for personalized advice based on individual health conditions.